HSP90 INHIBITORS POTENTIALLY OVERCOME CHEMORADIOTHERAPY RESISTANCE ASSOCIATED WITH HER2 AND NFfEB OVEREXPRESSION IN MIBC

被引:0
|
作者
Yoshida, Soichiro
Koga, Fumitaka
Tatokoro, Manabu
Kawakami, Satoru
Fujii, Yasuhisa
Kumagai, Jiro
Neckers, Len
Kihara, Kazunori
机构
来源
JOURNAL OF UROLOGY | 2011年 / 185卷 / 04期
关键词
D O I
10.1016/j.juro.2011.02.1091
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
1054
引用
收藏
页码:E424 / E424
页数:1
相关论文
共 50 条
  • [21] The Potential Dual-target Inhibitors for HER2/HSP90 Proteins from Traditional Chinese Medicine
    Chen, Jhih-Ying
    Chen, Chia-Min
    Chang, Pei-Chun
    Tsai, Jeffrey J. P.
    PROCEEDINGS 2018 IEEE 18TH INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOENGINEERING (BIBE), 2018, : 277 - 282
  • [22] Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma
    Enken Drecoll
    Ulrich Nitsche
    Karina Bauer
    Sabina Berezowska
    Julia Slotta-Huspenina
    Robert Rosenberg
    Rupert Langer
    International Journal of Colorectal Disease, 2014, 29 : 663 - 671
  • [23] Expression analysis of heat shock protein 90 (HSP90) and Her2 in colon carcinoma
    Drecoll, Enken
    Nitsche, Ulrich
    Bauer, Karina
    Berezowska, Sabina
    Slotta-Huspenina, Julia
    Rosenberg, Robert
    Langer, Rupert
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (06) : 663 - 671
  • [24] Leptin Increases HER2 Stability through HSP90 in Breast Cancer Cells
    Giordano, Cinzia
    Vizza, Donatella
    Rovito, Daniela
    Barone, Ines
    Bonofiglio, Daniela
    Panza, Salvatore
    Lanzino, Marilena
    Fuqua, Suzanne
    Catalano, Stefania
    Ando, Sebastiano
    FASEB JOURNAL, 2012, 26
  • [25] Blockade of Her2 binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2
    Fu, Liwu
    Zheng, Lisheng
    Yan, Yan-yan
    CANCER RESEARCH, 2011, 71
  • [26] Combining HSP90 Inhibition with Standard Therapies for HER2 Positive Breast Cancer
    Qadir, Z.
    Crown, J.
    Jensen, M. R.
    Clynes, M.
    Slamon, D.
    O'Donovan, N.
    CANCER RESEARCH, 2009, 69 (24) : 783S - 783S
  • [27] POTENTIAL ROLE OF HEAT SHOCK PROTEIN 90 INHIBITORS TO OVERCOME CHEMORADIOTHERAPY RESISTANCE ASSOCIATED WITH HER-2 AND NF-κB OVEREXPRESSION IN MUSCLE-INVASIVE BLADDER CANCER
    Koga, F.
    Yoshida, S.
    Tatokoro, M.
    Kawakami, S.
    Fujii, Y.
    Kumagai, J.
    Neckers, L.
    Kihara, K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 167 - 167
  • [28] Hsp90 restrains ErbB-2/HER2 signalling by limiting heterodimer formation
    Citri, A
    Gan, J
    Mosesson, Y
    Vereb, G
    Szollosi, J
    Yarden, Y
    EMBO REPORTS, 2004, 5 (12) : 1165 - 1170
  • [29] HSP90 inhibitors overcome drug resistance caused by FLT3 kinase domain mutations
    Yu, C.
    Kancha, R. K.
    Duyster, J.
    ONKOLOGIE, 2013, 36 : 209 - 209
  • [30] C-terminal hsp90 Inhibitors Overcome MEK and BRAF Inhibitor Resistance in Melanoma Dysplasia
    Spielbauer, Katie K.
    Subramanian, Chitra
    Cousineau, Eric
    Abdallah, Leah
    Jurecki, Lindsey
    Blagg, Brian
    Cohen, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 353 - 353